NASDAQ: MIRM
Mirum Pharmaceuticals Inc Stock Ownership - Who owns Mirum Pharmaceuticals?

Insider buying vs selling

Have Mirum Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christopher PeetzCHIEF EXECUTIVE OFFICER2025-02-039,102$48.22
$438.92kSell
Peter RadovichPRESIDENT AND COO2025-02-032,627$48.22
$126.68kSell
Jolanda HoweSVP GLOBAL CONTROLLER2025-02-031,064$48.22
$51.31kSell
Christopher PeetzCHIEF EXECUTIVE OFFICER2025-01-246,837$47.92
$327.66kSell
Jolanda HoweSVP GLOBAL CONTROLLER2025-01-24902$47.92
$43.23kSell
Peter RadovichPRESIDENT AND COO2025-01-243,177$47.93
$152.26kSell
Joanne QuanCHIEF MEDICAL OFFICER2025-01-176,969$45.86
$319.60kSell
Jolanda HoweSVP GLOBAL CONTROLLER2025-01-07750$42.82
$32.11kSell
Peter RadovichPRESIDENT AND COO2025-01-071,998$42.82
$85.54kSell
Christopher PeetzCHIEF EXECUTIVE OFFICER2025-01-077,489$42.82
$320.64kSell

1 of 3

MIRM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MIRM insiders and whales buy or sell their stock.

MIRM Shareholders

What type of owners hold Mirum Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Frazier Life Sciences Management LP13.69%6,570,392$329.90MInstitution
Janus Henderson Group PLC9.33%4,480,284$224.96MInstitution
Peter J. Barris8.72%4,186,243$210.19MInsider
Peter W. Sonsini8.72%4,186,243$210.19MInsider
David M. Mott8.72%4,186,243$210.19MInsider
Joshua Makower8.72%4,186,243$210.19MInsider
Patrick J. Heron7.77%3,729,220$187.24MInsider
Frazier Life Sciences IX LP7.43%3,566,912$179.09MInsider
Eventide Asset Management LLC7.18%3,445,363$172.99MInstitution
Blackrock Inc7.02%3,368,157$169.12MInstitution

1 of 3

MIRM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MIRM50.44%49.56%Net SellingNet Selling
ARWR76.96%10.90%Net SellingNet Selling
KYMR78.34%21.66%Net SellingNet Buying
APGE90.68%9.32%Net SellingNet Selling
VERA62.74%37.26%Net SellingNet Buying

Mirum Pharmaceuticals Stock Ownership FAQ

Who owns Mirum Pharmaceuticals?

Mirum Pharmaceuticals (NASDAQ: MIRM) is owned by 110.52% institutional shareholders, 108.61% Mirum Pharmaceuticals insiders, and 0.00% retail investors. Peter J. Barris is the largest individual Mirum Pharmaceuticals shareholder, owning 4.19M shares representing 8.72% of the company. Peter J. Barris's Mirum Pharmaceuticals shares are currently valued at $218.86M.

If you're new to stock investing, here's how to buy Mirum Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.